Neurobiology of Aging
Volume 31, Issue 3 , Pages 447-463 , March 2010

Age-dependent decline of steady state dopamine storage capacity of human brain: An FDOPA PET study

  • Yoshitaka Kumakura

      Affiliations

    • Centre for Functionally Integrative Neuroscience, Aarhus University, Denmark
    • Department of Nuclear Medicine, Graduate School of Medicine, The University of Tokyo, Japan
    • Corresponding Author InformationCorresponding author at: Centre for Functionally Integrative Neuroscience, Aarhus University, Norrebrogade 44, Aarhus C. 8000, Denmark. Tel.: +45 8949 3019; fax: +45 8949 3020.
    • ,
  • Ingo Vernaleken

      Affiliations

    • Department of Psychiatry and Psychotherapy, RWTH Aachen University, Germany
    • ,
  • Hans-Georg Buchholz

      Affiliations

    • Department of Nuclear Medicine, University of Mainz, Germany
    • ,
  • Per Borghammer

      Affiliations

    • Centre for Functionally Integrative Neuroscience, Aarhus University, Denmark
    • ,
  • Erik Danielsen

      Affiliations

    • Centre for Functionally Integrative Neuroscience, Aarhus University, Denmark
    • ,
  • Gerhard Gründer

      Affiliations

    • Department of Psychiatry and Psychotherapy, RWTH Aachen University, Germany
    • ,
  • Andreas Heinz

      Affiliations

    • Department of Psychiatry, Charité Hopsital, Berlin, Germany
    • ,
  • Peter Bartenstein

      Affiliations

    • Department of Nuclear Medicine, University of Mainz, Germany
    • Department of Nuclear Medicine, University of Munich, Germany
    • ,
  • Paul Cumming

      Affiliations

    • Centre for Functionally Integrative Neuroscience, Aarhus University, Denmark
    • Department of Nuclear Medicine, University of Munich, Germany

Received 26 January 2008 ,Revised 23 April 2008 ,Accepted 1 May 2008.

References 

  1. Amirjani N, Ashworth NL, Gordon T, Edwards DC, Chan KM. Normative values and the effects of age, gender, and handedness on the Moberg pick-up test. Muscle Nerve. 2007;35(6):788–792
  2. Arai R, Karasawa N, Geffard M, Nagatsu I. l-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci. Lett. 1995;195:195–198
  3. Behnke, S., Double, K.L., Duma, S., Broe, G.A., Guenther, V., Becker, G., Halliday, G.M., 2007. Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing, 34(3) 1054–1059.
  4. Berg D, Siefker C, Ruprecht-Dörfler P, Becker G. Relationship of substantia nigra echogenicity and motor function in elderly subjects. Neurology. 2001;56(1):13–17
  5. Blomqvist G. On the construction of functional maps in positron emission tomography. J. Cereb. Blood Flow Metab. 1984;4:629–632
  6. Borghammer P, Kumakura Y, Cumming P. [Letter] Fluorodopa F18 positron emission tomography studies and the progression of Parkinson's disease. Arch. Neurol. 2005;62:1480
  7. Brown WD, Taylor MD, Roberts AD, Aokes TR, Schueller MJ, Holden JE, et al. FluoroDOPA PET shows nondopaminergic as well as dopaminergic destinations of levodopa. Neurology. 1999;53:1212–1218
  8. Bunzeck, N., Schütze, H., Stallforth, S., Kaufmann, J., Düzel, S., Heinze, H.J., Düzel, E., 2007. Mesolimbic novelty processing in older adults. Cereb. Cortex, March 23 (Epub ahead of print).
  9. Collignon A, Maes F, Delaere D, Vandermeulen D, Suetens P, Marchal G. In:  Bizais Y,  Barillot C,  Di Paola R editor. Automated Multimodality Image Registration based on Information Theory” Information Processing in Medical Imaging. Dordrecht: Kluwer Academic Publishers; 1995;p. 263–274
  10. Crone C. The permeability of capillaries in various organs as determined by use of the ‘indicator diffusion’ method. Acta Physiol. Scand. 1963;58:292–305
  11. Cumming P, Gjedde A. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms. Synapse. 1998;29:37–61
  12. Cumming P, Boyes BE, Martin WRW, Adam M, Grierson J, Ruth T, et al. The metabolism of [18F]-6-fluoro-l-3,4-dihydroxyphenylalanine in the hooded rat. J. Neurochem. 1987;48:601–608
  13. Cumming P, Brown E, Damsma G, Fibiger HC. Formation and clearance of interstitial metabolites of dopamine and serotonin in rat striatum: an in vivo microdialysis study. J. Neurochem. 1992;59:1905–1914
  14. Cumming P, Léger G, Kuwabara H, Gjedde A. Pharmacokinetics of plasma 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine ([18F]FDOPA) in humans. J. Cereb. Blood Flow Metab. 1993;13:668–675
  15. Cumming P, Kuwabara H, Ase A, Gjedde A. Regulation of DOPA decarboxylase in brain of living rat. J. Neurochem. 1994;65:1381–1390
  16. Cumming P, Kuwabara H, Gjedde A. A kinetic analysis of [18F]-6-fluoro-l-dihydroxyphenylalanine ([18F]DOPA) metabolism in the rat. J. Neurochem. 1994;63:1675–1682
  17. Cumming P, Ljubic-Thibal V, Laliberté C, Diksic M. The effect of unilateral neurotoxic lesions to serotonin fibres in the medial forebrain bundle on the metabolism of [3H]DOPA in the telencephalon of living rat. Brain Res. 1997;747:60–69
  18. Cumming P, Munk OL, Doudet D. Loss of metabolites from monkey striatum during positron emission tomography with FDOPA. Synapse. 2001;41:212–218
  19. Cordes M, Snow BJ, Cooper S, Schulzer M, Pate BD, Ruth TJ, et al. Age-dependent decline of nigrostriatal dopaminergic function: a positron emission tomographic study of grandparents and their grandchildren. Ann. Neurol. 1994;36(4):667–670
  20. Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P. Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse. 2001;42:48–53
  21. Danielsen EH, Smith DF, Gee AD, Venkatachalam TK, Hansen SB, Hermansen F, et al. Cerebral 6-[(18)F]fluoro-l-DOPA (FDOPA) metabolism in pig studied by positron emission tomography. Synapse. 1999;33:247–258
  22. Deep P, Gjedde A, Cumming P. On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of 6-[18F]fluorodopamine in vivo. J. Neurosci. Methods. 1997;76:157–165
  23. Deep P, Kuwabara H, Gjedde A, Cumming P. The kinetic behaviour of [3H]DOPA in living rat brain investigated by compartmental modelling of static autoradiograms. J. Neurosci. Methods. 1997;78:157–168
  24. Dejesus OT, Endres CJ, Shelton SE, Nickles RJ, Holden JE. Noninvasive assessment of aromatic l-amino acid decarboxylase activity in aging rhesus monkey brain in vivo. Synapse. 2001;39(1):58–63
  25. Dhawan V, Ishikawa T, Patlak C, Chaly T, Robeson W, Belakhlef A, et al. Combined FDOPA and 3OMFD PET studies in Parkinson's disease. J. Nucl. Med. 1996;37:209–216
  26. Doudet DJ, Rosa-Neto P, Munk OL, Ruth TJ, Jivan S, Cumming P. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study. Neuroimage. 2006;30:26–35
  27. Eberling JL, Roberts JA, Taylor SE, VanBrocklin HF, O’Neil JP, Nordahl TE. No effect of age and estrogen on aromatic l-amino acid decarboxylase activity in rhesus monkey brain. Neurobiol. Aging. 2002;23(3):479–483
  28. Eidelberg D, Takikawa S, Dhawan V, Chaly T, Robeson W, Dahl R, et al. Striatal 18F-dopa uptake: absence of an aging effect. J. Cereb. Blood Flow Metab. 1993;13(5):881–888
  29. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proc. Natl. Acad. Sci. U.S.A. 1996;93:14065–14069
  30. Fowler JS, Logan J, Volkow ND, Wang GJ, MacGregor RR, Ding YS. Monoamine oxidase: radiotracer development and human studies (Review). Methods. 2002;27:263–277
  31. Frey KA, Koeppe RA, Kilbourne MR, Vander Borght TM, Albin RL, Gilman S, et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann. Neurol. 1996;40:873–884
  32. Gillings NM, Bender D, Falborg L, Marthi K, Munk OL, Cumming P. Kinetics of the metabolism of four PET radioligands in living minipigs. Nucl. Med. Biol. 2001;28:97–104
  33. Gjedde A. High- and low-affinity transport of d-glucose from blood to brain. J. Neurochem. 1981;36:1463–1471
  34. Gjedde A. Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination. Brain Res. 1982;257:237–274
  35. Gjedde A, Reith J, Dyve S, Léger G, Guttman M, Diksic M, et al. Dopa decarboxylase activity of the living human brain. Proc. Natl. Acad. Sci. U.S.A. 1991;88:2721–2725
  36. Gjedde A, Léger G, Cumming P, Yasuhara Y, Evans A, Guttman M, et al. Striatal l-DOPA decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis. J. Neurochem. 1993;61:1538–1541
  37. Gozlan H, Daval G, Verge D, Spampinato U, Fattaccini CM, Gallissot MC, et al. Aging associated changes in serotoninergic and dopaminergic pre- and postsynaptic neurochemical markers in the rat brain. Neurobiol. Aging. 1990;11:437–449
  38. Gründer G, Vernaleken I, Muller MJ, Davids E, Heydari N, Buchholz HG, et al. Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology. 2003;28(4):787–794
  39. Hartvig P, Lindner KJ, Tedroff J, Andersson Y, Bjurling P, Langstrom B. Brain kinetics of 11 C-labelled l-tryptophan and 5-hydroxy-l-tryptophan in the rhesus monkey. A study using positron emission tomography. J. Neural Transm. Gen. Sect. 1992;88:1–10
  40. Heinz A, Siessmeier T, Wrase J, Buchholz H-G, Gründer G, Kumakura Y, et al. Alcohol craving correlates with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined FDOPA and DMFP PET study in detoxified alcoholics. Am. J. Psychiatry. 2005;162:1515–1520
  41. Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, et al. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch. Neurol. 2005;62(3):378–382
  42. Holden JE, Doudet D, Endres CJ, Chan GL, Morrison KS, Vingerhoets FJ, et al. Graphical analysis of 6-fluoro-l-dopa trapping: effect of inhibition of catechol-O-methyltransferase. J. Nucl. Med. 1997;38:1568–1574
  43. Huang SC, Yu DC, Barrio JR, Grafton S, Melega WP, Hoffman JM, et al. Kinetics and modeling of l-6-[18F]fluoro-dopa in human positron emission tomographic studies. J. Cereb. Blood Flow Metab. 1991;11:898–913
  44. Kish SJ, Shannak KS, Rajput AH, Gilbert JJ, Hornykiewicz O. Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. Arch. Neurol. 1984;41:612–614
  45. Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. J. Neurochem. 1992;58:642–648
  46. Kish S, Zhong XH, Hornykiewicz O, Haycock JW. Striatal 3,4-dihydroxyphenylalanine decarboxlase in aging: disparity between post-mortem and positron emission tomography studies. Ann. Neurol. 1995;38:260–264
  47. Kumakura Y, Danielsen EH, Reilhac A, Gjedde A, Cumming P. The influx of [18F]fluorodopa to brain of normal volunteers and patients with Parkinson's disease: effect of levodopa. Acta Neurol. Scand. 2004;110:188–195
  48. Kumakura Y, Vernaleken I, Gründer G, Bartenstein P, Gjedde A, Cumming P. PET studies of net blood–brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity. J. Cereb. Blood Flow Metab. 2005;25:807–819
  49. Kumakura Y, Gjedde AH, Danielsen EH, Christensen S, Cumming P. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease; correlation with asymmetry of motor symptoms. J. Cereb. Blood Flow Metab. 2006;26:358–370
  50. Kumakura Y, Cumming P, Vernaleken I, Buchholz HG, Siessmeier T, Heinz A, et al. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia; an [18F]FDOPA/PET study. J. Neurosci. 2007;27(30):8080–8087
  51. Kuwabara H, Cumming P, Reith J, Leger G, Diksic M, Evans AC, et al. Human striatal l-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects. J. Cereb. Blood Flow Metab. 1993;13:43–56
  52. Laakso A, Vilkman H, Bergman J, Haaparanta M, Solin O, Syvälahti E, et al. Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol. Psychiatry. 2002;52(7):759–763
  53. Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur. J. Nucl. Med. 2000;27:867–869
  54. Lee CS, Samii A, Sossi V, Ruth TJ, Schultzer M, Holden JE, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic nerve terminals in Parkinson's disease. Ann. Neurol. 2000;47:493–503
  55. Leger G, Gjedde A, Kuwabara H, Guttman M, Cumming P. Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness. Synapse. 1998;30:351–361
  56. Leigland LA, Schulz LE, Janowsky JS. Age related changes in emotional memory. Neurobiol. Aging. 2004;25(8):1117–1124
  57. Martin WR, Palmer MR, Patlak CS, Calne DB. Nigrostriatal function in humans studied with positron emission tomography. Ann. Neurol. 1989;26:535–542
  58. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum. J. Cereb. Blood Flow Metab. 2001;21:1034–1057
  59. Mikhailova ON, Gulyaeva LF, Filipenko ML. Gene expression of drug metabolizing enzymes in adult and aged mouse liver: a modulation by immobilization stress. Toxicology. 2005;210:189–196
  60. Ota M, Yasuno F, Ito H, Seki C, Nozaki S, Asada T, et al. Age-related decline of dopamine synthesis in the living human brain measured by positron emission tomography with l-[beta-11C]DOPA. Life Sci. 2006;79(8):730–736
  61. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J. Cereb. Blood Flow Metab. 1985;5:584–590
  62. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 1983;3:1–7
  63. Pifl C, Hornykiewicz O. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochem. Int. 2006;49:519–524
  64. Rao K, Nagendra SN, Subhash MN. Monoamine oxidase isoenzymes in rat brain: differential changes during postnatal development but not aging. Neurobiol. Aging. 1995;16:833–836
  65. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am. J. Physiol. 1959;197:1205–1210
  66. Roggeveen AB, Prime DJ, Ward LM. Lateralized readiness potentials reveal motor slowing in the aging brain. J. Gerontol. B: Psychol. Sci. Soc. Sci. 2007;62(2):P78–84
  67. Ruprecht-Dörfler P, Berg D, Tucha O, Benz P, Meier-Meitinger M, Alders GL, et al. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease. Neuroimage. 2003;18(2):416–422
  68. Sawle GV, Colebatch JG, Shah A, Brooks DJ, Marsden CD, Frackowiak RS. Striatal function in normal aging: implications for Parkinson's disease. Ann. Neurol. 1990;28(6):799–804
  69. Sossi V, Doudet DJ, Holden JE. A reversible tracer analysis approach to the study of effective dopamine turnover. J. Cereb. Blood Flow Metab. 2001;21:469–476
  70. Sossi V, de La Fuente-Fernandez R, Holden JE, Doudet DJ, McKenzie J, Stoessl AJ, et al. Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18F-fluorodopa data. J. Cereb. Blood Flow Metab. 2002;22:232–239
  71. Sossi V, Holden JE, de la Fuente-Fernandez R, Ruth TJ, Stoessl AJ. Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki. J. Cereb. Blood Flow Metab. 2003;23:301–309
  72. Sossi V, de la Fuente-Fernandez R, Holden JE, Schulzer M, Ruth TJ, Stoessl J. Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms. J. Cereb Blood Flow Metab. 2004;24:869–876
  73. Sossi V, de la Fuente-Fernandez R, Schulzer M, Adams J, Stoessl J. Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications. Brain. 2006;129(Pt 4):1050–1058
  74. Sossi V, de la Fuente-Fernández R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ. Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study. Ann. Neurol. 2007;62:468–474
  75. Stark AK, Pakkenberg B. Histological changes of the dopaminergic nigrostriatal system in aging [Review]. Cell Tissue Res. 2004;318:81–92
  76. Stout DB, Huang SC, Namavari M, Satyamurthy N, Yee RE, Barrio JR. Distribution volume of 3-O-methyl-6. J. Cereb. Blood Flow Metab. 2000;20:1717–1724
  77. Torstenson, R., 1999. Functional regulation of the dopaminergic system in vivo: experimental and clinical studies with positron emission tomography (Comprehensive Summaries... from the Faculty of Pharmacy, 203) (Paperback) Publisher, Uppsala Universitet (December 1999).
  78. Vernaleken I, Kumakura Y, Cumming P, Buchholz HG, Siessmeier T, Stoeter P, et al. Modulation of [18F]fluorodopa (FDOPA) kinetics in brain of healthy volunteers after acute haloperidol challenge. Neuroimage. 2006;30:1332–1339
  79. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley SJ, et al. Dopamine transporters decrease with age. J. Nucl. Med. 1996;37:554–559
  80. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, MacGregor RR, et al. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res. 1996;67:11–16
  81. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J. Comput. Assist. Tomogr. 1992;16:620–633
  82. Wright CI, Wedig MM, Williams D, Rauch SL, Albert MS. Novel fearful faces activate the amygdala in healthy young and elderly adults. Neurobiol. Aging. 2006;27(2):361–374

PII: S0197-4580(08)00144-9

doi: 10.1016/j.neurobiolaging.2008.05.005

Neurobiology of Aging
Volume 31, Issue 3 , Pages 447-463 , March 2010

Article Tools

* Image Usage & Resolution